Chung Henry purchased $27K of CCAP

Chung Henry (President) purchased 2,500 shares of Crescent Capital BDC, Inc. (CCAP) at $10.89 on 2026-08-19.

Original reporting
SEC EDGAR · Chung Henry
Published Aug 21, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCAP
Neutral
high confidence
Mentioned
$CCAP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCAPNeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to influence trading decisions.

02

Market read

Minor insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or capital raises could make insider activity more relevant.

Relevance 4/10Novelty 3/10Timing: filing date 2026-08-21

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of confidence.

Company-level read

Ticker impact

$CCAPNeutralHigh confidence
Context

President Chung Henry bought 2,500 shares of Crescent Capital BDC for $27,225, increasing his stake to 23,917 shares.

Expected impact

Minimal effect on share price; unlikely to move market.

Evidence & confidence

The transaction amount is low relative to the company's market cap and typical trading volume.

Market effects

No significant implications for the BDC sector.

Limited to US markets; no broader regional effect.

None

Counterpoint

The purchase may be routine compensation rather than a strong bullish signal.

Key entities

  • Crescent Capital BDC, Inc.

    A business development company listed on NASDAQ under ticker CCAP.

  • Chung Henry

    President of Crescent Capital BDC.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CCAPHigh

Crescent Capital Q3 2026 slides: earnings beat, $50M buyback unveiled

Crescent Capital BDC (CCAP) reported Q3 2026 earnings of $0.37 per share, beating estimates. The company announced a $50M share buyback and a joint venture to reduce leverage. Shares rose 6.82% in after-hours trading to $9.87, still below NAV. Portfolio assets reached $1.6B, with 91% in senior secured positions. Net investment income declined year-over-year, and NAV per share fell 8%.

$CCAPMed

Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ

$CCAPMed

Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.36